This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
News: Publications

Commentary on DA Vinci study

Wednesday 16 September 2020   (0 Comments)
Share |

Commentary on DA VINCI study: Change in approach to cholesterol management will be needed to reduce

Results of DA VINCI, an EU Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care, underline the need for combination therapy for patients at highest risk and in whom the lowest LDL-C goals are recommended.

To the Featured Commentary by Dr Jane Stock >>

Membership Software Powered by YourMembership  ::  Legal